Related references
Note: Only part of the references are listed.Consolidation Therapy With Low-Dose Thalidomide and Prednisolone Prolongs the Survival of Multiple Myeloma Patients Undergoing a Single Autologous Stem-Cell Transplantation Procedure
Andrew Spencer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
A meta-analysis and systematic review of thalidomide for patients with previously untreated multiple myeloma
Lisa K. Hicks et al.
CANCER TREATMENT REVIEWS (2008)
Influence of Pre- and Post-Transplantation Responses on Outcome of Patients With Multiple Myeloma: Sequential Improvement of Response and Achievement of Complete Response Are Associated With Longer Survival
Juan Jose Lahuerta et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
被撤回的出版物: Single autologous stem-cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma:: results of a multicenter randomized clinical trial (Retracted article. See vol. 113, pg. 6265, 2009)
Abderrahman Abdelkefi et al.
BLOOD (2008)
Thalidomide maintenance following high-dose therapy in multiple myeloma: a UK myeloma forum phase 2 study
Sylvia Feyler et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Complete response correlates with long-term survival and progression-free survival in high-dose therapy in multiple myeloma
Helgi J. K. van de Velde et al.
HAEMATOLOGICA (2007)
Neuropathy in multiple myeloma treated with thalidomide - A prospective study
R. Plasmati et al.
NEUROLOGY (2007)
Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials
S. Jagannath et al.
LEUKEMIA (2007)
Maintenance, therapy with thalidomide improves survival in patients with multiple myeloma
Michel Attal et al.
BLOOD (2006)
International uniform response criteria for multiple myeloma
B. G. M. Durie et al.
LEUKEMIA (2006)
Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myeloma
F Sahebi et al.
BONE MARROW TRANSPLANTATION (2006)
Thalidomide and hematopoietic-cell transplantation for multiple myeloma
B Barlogie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Neurological toxicity of long-term (>1 yr) thalidomide therapy in patients with multiple myeloma
P Tosi et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
Consolidation therapy of multiple myeloma with thalidomide-dexamethasone after intensive chemotherapy
R Alexanian et al.
ANNALS OF ONCOLOGY (2002)
Share Paper
